byiShook Opinion
Sep 18, 2024 - 14:15
TG Therapeutics stock popped Wednesday after the company unveiled promising five-year test results for its multiple sclerosis drug, Briumvi. The post IBD 50's TG Therapeutics Surges On Five-Year Data For Multiple Sclerosis Drug appeared first on Investor's Business Daily.
TG Therapeutics stock popped Wednesday after the company unveiled promising five-year test results for its multiple sclerosis drug, Briumvi.
The post IBD 50's TG Therapeutics Surges On Five-Year Data For Multiple Sclerosis Drug appeared first on Investor's Business Daily.